These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23413976)

  • 1. Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study.
    Yasin A; Liu D; Chau L; Madrenas J; Filler G
    BMC Nephrol; 2013 Feb; 14():39. PubMed ID: 23413976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Isakova T; Cai X; Lee J; Mehta R; Zhang X; Yang W; Nessel L; Anderson AH; Lo J; Porter A; Nunes JW; Negrea L; Hamm L; Horwitz E; Chen J; Scialla JJ; de Boer IH; Leonard MB; Feldman HI; Wolf M;
    Am J Kidney Dis; 2020 Feb; 75(2):235-244. PubMed ID: 31668375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.
    Manghat P; Fraser WD; Wierzbicki AS; Fogelman I; Goldsmith DJ; Hampson G
    Osteoporos Int; 2010 Nov; 21(11):1853-61. PubMed ID: 20012018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?
    Wesseling-Perry K; Tsai EW; Ettenger RB; Jüppner H; Salusky IB
    Nephrol Dial Transplant; 2011 Nov; 26(11):3779-84. PubMed ID: 21441401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.
    Drew DA; Katz R; Kritchevsky S; Ix JH; Shlipak MG; Newman AB; Hoofnagle A; Fried L; Sarnak MJ; Gutierrez OM
    Am J Nephrol; 2018; 47(4):242-250. PubMed ID: 29621752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deviations from the expected relationship between serum FGF23 and other markers in children with CKD: a cross-sectional study.
    Liu D; Alvarez-Elías AC; Wile B; Belostotsky V; Filler G
    BMC Nephrol; 2017 Jun; 18(1):204. PubMed ID: 28659167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 (FGF 23) and phosphocalcic metabolism in chronic kidney disease.
    Torguet-Escuder P; Guasch-Aragay B; Calabia-Martínez J; Martín-Alemany N; García-Méndez I; Maté-Benito G; Clapés-Sánchez E; Sabater-Masdeu M; Fernández-Real JM; Vallès-Prats M
    Nefrologia; 2012; 32(5):647-54. PubMed ID: 23013951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF-23 and Phosphate in Children with Chronic Kidney Disease: A Cross-Sectional Study in Kazakhstan.
    Balmukhanova A; Kabulbayev K; Alpay H; Kanatbayeva A; Balmukhanova A
    Medicina (Kaunas); 2020 Dec; 57(1):. PubMed ID: 33379157
    [No Abstract]   [Full Text] [Related]  

  • 10. Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients.
    Kanda E; Yoshida M; Sasaki S
    BMC Nephrol; 2012 Sep; 13():122. PubMed ID: 23013306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of fibroblast growth factor-23 in children with chronic kidney disease.
    Magnusson P; Hansson S; Swolin-Eide D
    Scand J Clin Lab Invest; 2010 Feb; 70(1):15-20. PubMed ID: 19929273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
    Muras K; Masajtis-Zagajewska A; Nowicki M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
    Evenepoel P; Meijers B; Viaene L; Bammens B; Claes K; Kuypers D; Vanderschueren D; Vanrenterghem Y
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1268-76. PubMed ID: 20448073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are fibroblast growth factor 23 concentrations in renal transplant patients different from non-transplanted chronic kidney disease patients?
    Filler G; Liu D; Sharma AP; Grimmer J
    Pediatr Transplant; 2012 Feb; 16(1):73-7. PubMed ID: 22121948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
    Smith K; deFilippi C; Isakova T; Gutiérrez OM; Laliberte K; Seliger S; Kelley W; Duh SH; Hise M; Christenson R; Wolf M; Januzzi J
    Am J Kidney Dis; 2013 Jan; 61(1):67-73. PubMed ID: 22883134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease.
    Harjes LM; Parker VJ; Dembek K; Young GS; Giovaninni LH; Kogika MM; Chew DJ; Toribio RE
    J Vet Intern Med; 2017 May; 31(3):784-790. PubMed ID: 28419560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
    Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE
    J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fibroblast growth factor 23 levels do not correlate with carotid intima-media thickness in patients with chronic kidney disease.
    Kaya B; Seyrek N; Paydas S; Karayaylali İ; Balal M; Aikimbaev K
    Saudi J Kidney Dis Transpl; 2019; 30(5):1010-1021. PubMed ID: 31696838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy.
    Liao HW; Hung PH; Hsiao CY; Liou HH; Lin HS; Huang TH; Jou IM; Tsai KJ
    PLoS One; 2015; 10(7):e0133278. PubMed ID: 26186634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in FGF-23, Neutrophil/Platelet Activation Markers, and Angiogenin in Advanced Chronic Kidney Disease and Their Effect on Arterial Stiffness.
    Choi HM; Kwon YE; Kim S; Oh DJ
    Kidney Blood Press Res; 2019; 44(5):1166-1178. PubMed ID: 31553973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.